BEEOLED
LIVE

Serial Number

98270939

Owner

beeOLED GmbH

Attorney

David Lipson

Filing Date

Nov 15, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BEEOLED Trademark

Serial Number: 98270939

BEEOLED is a trademark filed by beeOLED GmbH on November 15, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

beeOLED GmbH

Niedersedlitzer Strasse 75c
01257 Dresden 01257 , DE

Entity Type: 27

Trademark Details

Filing Date

November 15, 2023

Registration Date

Not Registered

Published for Opposition

October 1, 2024

Goods & Services

Chemicals for use in industry and science; industrial chemicals, namely, chemicals for use in the pharmaceutical industry; industrial chemicals, namely, chemicals for use in the electrical industry; industrial chemicals, namely, chemicals for use in the microelectronics industry; industrial chemicals, namely, chemicals for use in the electroplating industry; industrial chemicals, namely, chemicals for use in the semiconductor industry; chemicals for use in the manufacture of organic light emitting diodes; doping compounds for use in the manufacture of semiconductors; doping compounds for use in the manufacture of printed circuit boards; fluorescent dye for scientific or research use; OLED (Organic light emitting diode) emitter materials in the nature of chemicals for use in industry and science; OLED (Organic light emitting diode) dopant materials in the nature of chemicals for use in industry and science; OLED (Organic light emitting diode) host materials in the nature of chemicals for use in industry and science; chemicals for use in the manufacture of electronic displays; chemicals for use in the manufacture of electronic flat panel displays; chemicals for use in the manufacture of OLED (Organic light emitting diode) lighting; chemicals for use in the manufacture of OLED (Organic light emitting diode) signage; chemicals for use in the manufacture of infrared (IR) light emitting diodes; infrared (IR) light emitting materials in the nature of chemicals for use in industry and science; chemicals for use in the manufacture of near infrared (NIR) light emitting diodes; near infrared (NIR) light emitting materials in the nature of chemicals for use in industry and science; chemicals for use in the manufacture of short wavelength infrared (SWIR) light emitting diodes; short wavelength infrared (SWIR) light emitting materials in the nature of chemicals for use in industry and science; catalysts for use in the manufacture of industrial chemicals; photocatalysts; enzymes for industrial purposes; photoenzymes for industrial purposes; biochemical catalysts for industrial purposes; catalysts for chemical and biochemical processes, namely, catalysts for carbon dioxide (CO2) utilization reactions; catalysts for chemical and biochemical processes, namely, catalysts for polymerization reactions; synthetic catalysts for chemical and biochemical processes; synthetic enzymes for industrial purposes; synthetic photoenzymes for industrial purposes; chemical source material for the deposition of thin films upon semiconductor wafers for the manufacture of semiconductors; chemicals for use in industry and science, namely, chemical vapor deposition; chemicals for use in industry and science, namely, physical vapor deposition; industrial chemicals for use as precursor materials for metal ion deposition; industrial chemicals for use as precursor materials for semiconductor dopants

Contrasting agents for ultrasound diagnostic imaging; contrast media for in vivo imaging; radiological contrast substances for medical purposes; diagnostic reagents and contrast media for medical use; contrast media for use with imaging medical equipment; contrast media for use with medical magnetic resonance imaging equipment; contrast media for use with medical magnetic resonance tomography equipment; diagnostic radiopharmaceutical preparations; diagnostic radiopharmaceutical agents for use in PET (Positron Emission Tomography) imaging; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; radiopharmaceutical agents for use in amyloid pathology detection; radiopharmaceutical products, namely, diagnostic radiopharmaceutical preparations; radiopharmaceuticals for therapy and diagnostics, namely, radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use, namely, radionuclides for therapy and diagnostics; pharmaceuticals, namely, diagnostic radiopharmaceutical agents for use in SPECT (Single-Photon Emission Computed Tomography) medical imaging; therapeutic radiopharmaceuticals for cancer treatment; therapeutic radiopharmaceuticals for oncology; cardiovascular pharmaceuticals, namely, therapeutic radiopharmaceuticals for cardiology; therapeutic radiopharmaceuticals for neurology, namely, for treatment of neurological conditions; materials for theranostics, namely, radioactive substances for medical purposes; synthetic enzymes for medical purposes

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 24, 2026 EXRA
SOU EXTENSION 3 GRANTED
Apr 23, 2026 EX3G
SOU EXTENSION 3 FILED
Apr 23, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 23, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 16, 2025 EXRA
SOU EXTENSION 2 GRANTED
Oct 15, 2025 EX2G
SOU EXTENSION 2 FILED
Oct 15, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 15, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 15, 2025 EXRA
SOU EXTENSION 1 GRANTED
Apr 15, 2025 EX1G
SOU EXTENSION 1 FILED
Apr 14, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 14, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 26, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 27, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 27, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 27, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 27, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 27, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 11, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 11, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 11, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 20, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 20, 2023 NWOS
NEW APPLICATION ENTERED
Nov 18, 2023 NWAP